Eli Lilly and Company And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – Eli Lilly and Company (LLY), Genpact Limited (G), Allianceberstein Holding L.P. Units (AB) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Eli Lilly and Company (LLY)

28.1% sales growth and 65.6% return on equity

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Earnings Per Share

As for profitability, Eli Lilly and Company has a trailing twelve months EPS of $7.17.

PE Ratio

Eli Lilly and Company has a trailing twelve months price to earnings ratio of 82.42. Meaning, the purchaser of the share is investing $82.42 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 65.6%.

Volume

Today’s last reported volume for Eli Lilly and Company is 1312750 which is 56.83% below its average volume of 3041050.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Eli Lilly and Company’s EBITDA is 207.13.

Revenue Growth

Year-on-year quarterly revenue growth grew by 28.1%, now sitting on 29.52B for the twelve trailing months.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 107.6% and positive 47.8% for the next.

2. Genpact Limited (G)

10.6% sales growth and 22.15% return on equity

Genpact Limited provides business process outsourcing and information technology (IT) services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Banking, Capital Markets and Insurance; Consumer Goods, Retail, Life Sciences and Healthcare; and High Tech, Manufacturing and Services. The company offers CFO advisory services; and environmental, social, and governance (ESG) services, such as data management, carbon accounting, human rights assessment, sustainability diligence, and ESG reporting. It also provides finance and accounting services, which include accounts payable, such as document management, invoice processing, approval and resolution management, and travel and expense processing; invoice-to-cash services, including customer master data management, credit and contract management, fulfillment, billing, collections, and dispute management services; record to report services comprising accounting, treasury, tax, product cost accounting, and closing and reporting services; financial planning and analysis consisting of budgeting, forecasting, and business performance reporting; and enterprise risk and compliance services, including operational risks and controls. In addition, the company provides supply chain advisory services, and after-sales services; sourcing and procurement services comprising direct and indirect strategic sourcing, category management, spend analytics, procurement operation, and master data management; and sales and commercial services, including campaign, order, and dispute management, lead generation, pricing, and promotion optimization. Further, it offers IT services, which comprise end-user computing support, infrastructure management, application production support, and database management services; and transformation services that include digital solutions, consulting services, and analytics services and solutions. The company was founded in 1997 and is based in Hamilton, Bermuda.

Earnings Per Share

As for profitability, Genpact Limited has a trailing twelve months EPS of $2.18.

PE Ratio

Genpact Limited has a trailing twelve months price to earnings ratio of 16.89. Meaning, the purchaser of the share is investing $16.89 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.15%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 1.5%, now sitting on 4.41B for the twelve trailing months.

3. Allianceberstein Holding L.P. Units (AB)

10.4% sales growth and 14.16% return on equity

AllianceBernstein Holding L.P. is publicly owned investment manager. The firm also provides research services to its clients. It provides its services to investment companies, pension and profit sharing plans, banks and thrift institutions, trusts, estates, government agencies, charitable organizations, individuals, corporations, and other business entities. The firm invests in public equity, fixed income, and alternative investment markets across the globe. It employs long/short strategy to make its investments. The firm conducts in-house research to make its investments. AllianceBernstein Holding L.P. was founded in 1987 and is based in New York, New York.

Earnings Per Share

As for profitability, Allianceberstein Holding L.P. Units has a trailing twelve months EPS of $2.26.

PE Ratio

Allianceberstein Holding L.P. Units has a trailing twelve months price to earnings ratio of 13.68. Meaning, the purchaser of the share is investing $13.68 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.16%.

Moving Average

Allianceberstein Holding L.P. Units’s worth is under its 50-day moving average of $31.16 and way below its 200-day moving average of $34.44.

4. Kirby Corporation (KEX)

8.1% sales growth and 5.78% return on equity

Kirby Corporation operates domestic tank barges in the United States. Its Marine Transportation segment provides marine transportation services and towing vessels transporting bulk liquid products, as well as operates tank barges throughout the Mississippi River System, on the Gulf Intracoastal Waterway, coastwise along three United States coasts, and in Alaska and Hawaii. This segment also transports petrochemicals, black oil, refined petroleum products, and agricultural chemicals by tank barges; and operates offshore dry-bulk barge and tugboat units that are engaged in the offshore transportation of dry-bulk cargoes in the United States coastal trade. As of December 31, 2019, this segment owned and operated 1,053 inland tank barges with 23.4 million barrels of capacity, 299 inland towboats, 49 coastal tank barges with 4.7 million barrels of capacity, 47 coastal tugboats, 4 offshore dry-bulk cargo barges, 4 offshore tugboats, and 1 docking tugboat. The company's Distribution and Services segment sells replacement parts; provides service mechanics to overhaul and repair engines, transmissions, reduction gears, and related oilfield services equipment; rebuilds component parts or diesel engines, transmissions and reduction gears, and related equipment used in oilfield services, marine, power generation, on-highway, and other industrial applications; rents industrial compressors, railcar movers, and high capacity lift trucks; and manufactures and remanufactures oilfield service equipment, including pressure pumping units. It serves oilfield service, on-highway transportation, marine transportation, commercial fishing, construction, and power generation companies, as well as oil and gas operators and producers, and the United States government. The company was formerly known as Kirby Exploration Company, Inc. and changed its name to Kirby Corporation in 1990. Kirby Corporation was founded in 1921 and is headquartered in Houston, Texas.

Earnings Per Share

As for profitability, Kirby Corporation has a trailing twelve months EPS of $2.87.

PE Ratio

Kirby Corporation has a trailing twelve months price to earnings ratio of 28.65. Meaning, the purchaser of the share is investing $28.65 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.78%.

Leave a Reply

Your email address will not be published. Required fields are marked *